Skye Biologics Holdings
PrivateLast Round
Private Placement
Mar 13, 2024
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Skye Biologics Holdings is a biotechnology company that discovers and develops therapeutics from human biological material to treat degenerative diseases, damaged tissue, injuries, and trauma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skye Biologics Holdings Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Skye Biologics Holdings Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 13, 2024 | ||||
| Private Placement | Jan 31, 2024 | ||||
| Private Placement | Aug 18, 2023 | ||||
| Convertible Debt | Aug 18, 2023 |
Skye Biologics Holdings Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Velan Capital | Private Placement |
| Perceptive Advisors | Private Placement |
| Schonfeld Strategic Advisors | Private Placement |
| Ally Bridge Group | Private Placement |
| Altium Capital | Private Placement |
| 5AM Ventures | Private Placement |
| Versant Ventures | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 110% MoM, reaching 1K.
Skye Biologics Holdings Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Skye Biologics Holdings's valuation, stock price, and market status.